Suppr超能文献

高收入国家向免疫联盟过渡国家可持续免疫体系面临的挑战。

Challenges to sustainable immunization systems in Gavi transitioning countries.

机构信息

World Health Organization, Geneva, Switzerland.

University of Toronto, Canada.

出版信息

Vaccine. 2018 Oct 29;36(45):6858-6866. doi: 10.1016/j.vaccine.2018.06.012. Epub 2018 Sep 27.

Abstract

The Global Vaccine Action Plan 2011-2020 (GVAP) aims to extend the full benefit of vaccination against vaccine-preventable diseases to all individuals. More than halfway through the Decade of Vaccines, countries classified as Middle-Income by the World Bank struggle to achieve several GVAP targets. Countries transitioning from Gavi, the Vaccine Alliance, represent a key sub-group of Middle Income Countries. Through a review of available literature on the subject, this study documents the lack of comparative analyses on immunization system performance in countries transitioning from Gavi support. Despite increased emphasis on the importance of programmatic sustainability beyond financing through the Gavi 2016-2020 Strategy and availability of data, existing literature has predominantly documented challenges related to domestic financing of immunization. This study complements a review of current literature with an analysis of country assessments conducted by immunization partners since 2011, in an effort to document programmatic challenges related to decision-making for immunization policy, delivery of services, and access to affordable and timely supply in Gavi transitioning countries. In light of the findings, we suggest continued systematic compilation of country performance data beyond financing to inform policy-making, in particular for: (i) development of a more nuanced theory of change towards sustainable immunization programmes and (ii) measurement of progress and key areas for attention and investment.

摘要

《2011-2020 年全球疫苗行动计划》(GVAP)旨在使所有人都能充分受益于预防疫苗可预防疾病的疫苗接种。在疫苗十年进行到一半的时候,世界银行分类为中等收入的国家难以实现全球疫苗行动计划的几个目标。正在从疫苗联盟(Gavi)过渡的国家是中等收入国家中的一个关键亚组。通过对该主题现有文献的审查,本研究记录了在正在从 Gavi 支持过渡的国家中,关于免疫规划系统绩效的比较分析缺乏的情况。尽管通过 Gavi 2016-2020 年战略强调了除供资以外方案可持续性的重要性,并且可获得数据,但现有文献主要记录了与免疫规划的国内供资有关的挑战。本研究通过对自 2011 年以来免疫伙伴进行的国家评估进行分析,对当前文献的审查进行了补充,以记录与免疫政策决策、服务提供以及获得负担得起和及时供应有关的方案挑战,这些国家正在从 Gavi 过渡。有鉴于此,我们建议在供资以外继续系统地编制国家绩效数据,以支持决策,特别是为以下方面:(i) 制定更精细的可持续免疫规划方案变化理论,以及 (ii) 衡量进展情况以及需要关注和投资的关键领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85ea/6203805/48bb7066f842/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验